Ac-Tyr(Me)-OMe

Ac-Tyr(Me)-OMe is an N-acetylated, O-methyl-protected tyrosine derivative in which the phenolic side chain is substituted with a methyl group, giving a protected aromatic amino acid building block with reduced phenolic reactivity. The acetylated N-terminus and methyl ester at the C-terminus make it a stable, non-zwitterionic intermediate that is commonly handled as a peptide segment precursor rather than as a free amino acid. This structure supports controlled assembly of tyrosine-containing sequences and side-chain-specific studies where phenolic functionality is intentionally masked.

1. Peptide Segment Building

Ac-Tyr(Me)-OMe is used as a protected tyrosine-containing segment for peptide synthesis workflows that require a blocked phenolic side chain and a defined C-terminal methyl ester. Peptide chemistry groups employ this derivative when they want to incorporate a tyrosine residue variant while minimizing side reactions from the phenolic oxygen during coupling and subsequent transformations. The N-acetyl and ester protection pattern also helps maintain segment integrity through condensation steps, supporting reproducible preparation of short peptides and protected intermediates for custom peptide manufacturing and research-scale library synthesis.

2. Protected Tyrosine Analog Studies

Ac-Tyr(Me)-OMe is frequently selected for chemical biology and medicinal chemistry research programs that evaluate tyrosine-dependent motifs under conditions where phenolic reactivity needs to be suppressed. By using a methylated phenolic side chain and a protected terminus, researchers can probe how steric and electronic changes at the aromatic hydroxyl position influence peptide behavior in binding assays, structure-function studies, or protease/peptidase substrate experiments where uncontrolled phenol chemistry would complicate interpretation. This derivative is therefore a practical building block for generating tyrosine analog peptides with consistent side-chain protection throughout downstream testing.

3. Pharmaceutical Intermediate Development

Ac-Tyr(Me)-OMe serves as a protected amino acid intermediate for the preparation of tyrosine-derived fragments used in medicinal chemistry and process chemistry development. Pharmaceutical intermediate teams rely on N-acetylation and C-terminal ester protection to reduce handling variability and to enable stepwise conversion into more advanced, functionalized building blocks. The methylated aromatic side chain provides a protected platform that can be carried through intermediate stages without phenolic interference, supporting the synthesis of protected peptide-like motifs and related small-molecule scaffolds where controlled functional group presentation is required.

1. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling